Holen Sie sich die Stockscreener-App
25.36
0.04%
-0.01
Handel nachbörslich:
25.36
Schlusskurs vom Vortag:
$25.37
Offen:
$25.54
24-Stunden-Volumen:
355.78K
Relative Volume:
0.81
Marktkapitalisierung:
$1.18B
Einnahmen:
$722.68M
Nettoeinkommen (Verlust:
$134.71M
KGV:
9.4981
EPS:
2.67
Netto-Cashflow:
$109.94M
1W Leistung:
-3.83%
1M Leistung:
+6.87%
6M Leistung:
+1.16%
1J Leistung:
-42.48%
1-Tages-Spanne:
$24.92
$26.01
1-Wochen-Bereich:
$24.92
$26.57
52-Wochen-Spanne:
$20.39
$46.43
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Firmenname
Amphastar Pharmaceuticals Inc
Sektor
Telefon
909-980-9484
Adresse
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Vergleichen Sie AMPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
25.36 | 1.17B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Hochstufung | Needham | Hold → Buy |
| 2025-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-03-05 | Eingeleitet | JP Morgan | Overweight |
| 2023-11-17 | Eingeleitet | BofA Securities | Neutral |
| 2023-07-25 | Fortgesetzt | Jefferies | Buy |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-07-29 | Eingeleitet | CapitalOne | Overweight |
| 2022-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Eingeleitet | Northland Capital | Outperform |
| 2019-03-13 | Herabstufung | Needham | Buy → Hold |
| 2019-03-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Bestätigt | Needham | Buy |
| 2018-03-13 | Bestätigt | Needham | Buy |
| 2017-12-01 | Bestätigt | Needham | Buy |
| 2017-11-09 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Bestätigt | Needham | Buy |
| 2017-03-14 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Bestätigt | Needham | Buy |
| 2016-05-10 | Bestätigt | Needham | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2015-06-19 | Bestätigt | Needham | Buy |
| 2015-06-03 | Eingeleitet | Raymond James | Strong Buy |
| 2014-07-21 | Eingeleitet | Needham | Buy |
Alle ansehen
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Amphastar Pharmaceuticals : Q3 Financial Results (AMP 2025 Q3 Earnings Release FINAL) - MarketScreener
How Amphastar Pharmaceuticals Inc. stock reacts to oil pricesQuarterly Trade Summary & Growth Focused Entry Point Reports - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover faster than marketWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leaderJuly 2025 Spike Watch & Expert Approved Momentum Trade Ideas - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock is listed among top recommendationsJuly 2025 Fed Impact & Real-Time Market Trend Scan - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock boost dividends furtherJuly 2025 Outlook & Reliable Intraday Trade Plans - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock recover faster than industryWeekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
How risky is Amphastar Pharmaceuticals Inc. (29A) stock compared to peersWeekly Investment Summary & Technical Pattern Based Signals - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder value2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock good for long term investingJuly 2025 Movers & Daily Stock Trend Reports - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Bear Alert & AI Powered Buy/Sell Recommendations - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Quarterly Trade Summary & Weekly Chart Analysis and Trade Guides - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Setups & Daily Stock Trend Watchlist - newser.com
Floyd Petersen Sells 16,679 Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock - MarketBeat
Campbell & CO Investment Adviser LLC Sells 23,356 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Is Amphastar Pharmaceuticals Inc. stock supported by strong cash flowsGap Down & Stock Timing and Entry Methods - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosWeekly Trade Report & High Yield Equity Trading Tips - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Finanzdaten der Amphastar Pharmaceuticals Inc-Aktie (AMPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.17%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):